GlaxoSmithKline plc (GSK) stock is lower by -4.39% over the last 12 months, and the average rating from Wall Street analysts is a Buy. InvestorsObserver’s proprietary ranking system, gives GSK stock a score of 28 out of a possible 100.
That rank is mainly influenced by a long-term technical score of 8. GSK's rank also includes a short-term technical score of 11. The fundamental score for GSK is 66. In addition to the average rating from Wall Street analysts, GSK stock has a mean target price of 44.925. This means analysts expect the stock to rise 18.01% over the next 12 months.
What's Happening with GSK Stock Today
GlaxoSmithKline plc (GSK) stock has gained 5.36% while the S&P 500 is higher by 0.72% as of 9:36 AM on Thursday, Apr 15. GSK is higher by $1.93 from the previous closing price of $36.13 on volume of 3,459,283 shares. Over the past year the S&P 500 has risen 49.25% while GSK is lower by -4.39%. GSK earned $3.14 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 12.08.